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Addiction tomajor drugs of abuse, such as cocaine, has recently been linked to alterations in
adult neurogenesis in the hippocampus. The endogenous cannabinoid system modulates
this proliferative response as demonstrated by the ﬁnding that pharmacological activa-
tion/blockade of cannabinoid CB1 and CB2 receptors not only modulates neurogenesis but
also modulates cell death in the brain. In the present study, we evaluated whether the
endogenous cannabinoid system affects cocaine-induced alterations in cell proliferation.
To this end, we examined whether pharmacological blockade of either CB1 (Rimonabant,
3 mg/kg) or CB2 receptors (AM630, 3 mg/kg) would affect cell proliferation [the cells were
labeled with 5-bromo-2′-deoxyuridine (BrdU)] in the subventricular zone (SVZ) of the lateral
ventricle and the dentate subgranular zone (SGZ). Additionally, we measured cell apoptosis
(as monitored by the expression of cleaved caspase-3) and glial activation [by analyzing the
expression of glial ﬁbrillary acidic protein (GFAP) and Iba-1] in the striatum and hippocampus
during acute and repeated (4 days) cocaine administration (20 mg/kg). The results showed
that acute cocaine exposure decreased the number of BrdU-immunoreactive (ir) cells in
the SVZ and SGZ. In contrast, repeated cocaine exposure reduced the number of BrdU-ir
cells only in the SVZ. Both acute and repeated cocaine exposure increased the number
of cleaved caspase-3-, GFAP- and Iba1-ir cells in the hippocampus, and this effect was
counteracted by AM630 or Rimonabant, which increased the number of BrdU-, GFAP-, and
Iba1-ir cells in the hippocampus. These results indicate that the changes in neurogenic,
apoptotic and gliotic processes that were produced by repeated cocaine administration
were normalized by pharmacological blockade of CB1 and CB2. The restorative effects
of cannabinoid receptor blockade on hippocampal cell proliferation were associated with
the prevention of the induction of conditioned locomotion but not with the prevention of
cocaine-induced sensitization.
Keywords: cocaine, neurogenesis, cannabinoid receptors, Rimonabant, AM630, inflammation, hippocampus,
striatum
INTRODUCTION
Addiction is a chronic disorder in which contextual memories
play important roles in drug-taking and drug-seeking (Koob
and Volkow, 2010). These contextual memories associate spe-
ciﬁc environments/stimuli with the reinforcing properties of
drugs. The hippocampus is likely involved in these responses
Abbreviations: BrdU, 5-bromo-2′-deoxyuridine; CA1/3, ﬁeld 1/3 of the Cornu
Ammonis; DG, dentate gyrus; gcl, granular cell layer; ml, molecular layer; pcl,
polymorphic cell layer; SGZ, subgranular zone of dentate gyrus; SL-M, stratum
lacunosum-moleculare; SO, stratum oriens; SP, stratum pyramidale; SR, stratum
radiatum; SVZ, subventricular zone of the lateral ventricles.
because of its role in forming context-speciﬁc memories that are
associated with conditioned responses that boost drug-seeking
(McFarland and Kalivas, 2001; Koob and Volkow, 2010). In the
case of psychostimulant exposure, repeated administration of
either cocaine or amphetamine results in enhanced psychomotor
responses that are a form of implicit memory called sensitization.
Sensitization is not linked to contextual associations; rather, sen-
sitization is linked to plasticity in the dopaminergic signaling in
the circuits of the ventral tegmental area, nucleus accumbens, and
dorsal striatum (Pierce and Kalivas, 1997; Carlezon and Nestler,
2002). Understanding how these memories (either contextual or
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implicit) lead to addicted phenotypes might help to address the
problem of preventing the reinstatement of drug-seeking, which
is a core problem for addiction therapeutics.
Oneof the neuroplasticitymechanismsbywhichhabit-forming
drugs may lead to addiction is the substitution and incorpora-
tion of new neurons and glial cells into reward and memory
circuits. The brain retains the ability to continuously generate
new cells from progenitors that are located in two main prolifer-
ative areas, the subventricular zone (SVZ) of the lateral ventricle
and the subgranular zone (SGZ) in the dentate gyrus (DG) of the
hippocampus (Gould et al., 1999; Shors et al., 2001). Additional
proliferative responses that are associated with the generation
of glial cells have been described in the cortex, particularly in
the medial prefrontal cortex (Mandyam and Koob, 2012). While
the cells generated in the SVZ primarily migrate to the olfactory
bulb, some of the migrating cells progress to adjacent areas that
include the striatal complex. SGZ cells differentiate, remain in the
hippocampal formation, and are thought to be essential for the
remodeling of memories associated with biographic events (Shors
et al., 2001).
In recent years, compelling evidence has demonstrated that
alterations in the rate of cell proliferation in the adult hip-
pocampus may regulate drug-seeking and drug-taking. This
phenomenon has been demonstrated for cocaine (Dominguez-
Escriba et al., 2006; Noonan et al., 2010), amphetamines
(Mandyam et al., 2008; Recinto et al., 2012), alcohol (Herrera
et al., 2003; He et al., 2005), nicotine (Shingo and Kito, 2005),
cannabinoids (Rueda et al., 2002; Jiang et al., 2005), and opiates
(Eisch et al., 2000). Although in some cases (mostly depending
on the dose delivered), drugs of abuse enhance neurogenesis [see
for instance (Jiang et al., 2005)], these studies have shown that
drugs of abuse decrease adult cell proliferation/neurogenesis. The
resulting reduction in neuronal turnover sustains drug-seeking
by preserving contextual memories associated with drug reward
(Mandyam and Koob, 2012). In the case of cocaine, neurogene-
sis has been linked to the protection of cocaine-primed relapse
(Deschaux et al., 2012), and to the facilitation of the extinc-
tion of cocaine-induced place preference (Mustroph et al., 2011),
whereas the impairment of neurogenesis increases behavioral
sensitization in a rat model (Garcia-Fuster et al., 2010), facili-
tates cocaine self-administration by extending the time required
for the extinction of this behavior (Noonan et al., 2010) and
generates deﬁcits in working memory (Sudai et al., 2011). More-
over, some of these effects are reversed after cocaine withdrawal
(Noonan et al., 2008).
One molecular mechanism that controls cell proliferation in
the adult brain, particularly in the hippocampus, is mediated
by the endogenous cannabinoid system. This lipid signaling sys-
tem not only regulates embryonic cell fate in the developing
brain but also regulates adult neurogenesis (Aguado et al., 2005;
Goncalves et al., 2008; Diaz-Alonso et al., 2012). This effect is
mediated through the activations of CB1 and CB2 receptors (Jin
et al., 2004; Hill et al., 2010). The effects of the endogenous
cannabinoid system can be bidirectional; i.e., the endogenous
cannabinoid system can promote cell proliferation during devel-
opment or after brain insult (Aguado et al., 2005, 2007) or reduce
cell proliferation when overstimulated by the administration of
cannabinoids (Rueda et al., 2002; Hill et al., 2006). The contribu-
tion of the endogenous cannabinoid system to cocaine-induced
alterations in neurogenesis is not known. However, there is clear
evidence that both CB1 and CB2 receptors are linked to the gen-
eration of contextual memories associated with cocaine-induced
sensitization and cocaine seeking and relapse (Gorriti et al., 1999;
De Vries et al., 2001; Gerdeman et al., 2008; Alvaro-Bartolome and
Garcia-Sevilla, 2013). To further explore the role of the endoge-
nous cannabinoid system in regulating memories associated with
cocaine exposure, the present study examined whether the block-
ade of either CB1 or CB2 cannabinoid receptors during repeated
administration of cocaine is capable of (a) affecting the acquisition
of cocaine-induced sensitization, (b) disrupting the appearance
of cocaine-induced conditioned locomotion, or (c) modulating
cocaine-induced cell proliferation.
MATERIALS AND METHODS
ANIMALS
All experimental animal procedures were performed in compli-
ance with the European Directive 2010/63/EU on the protection of
animals used for scientiﬁc purposes and with Spanish regulations
(RD 53/2013 and 178/2004). Male Wistar rats (approximately
250 g, 10–12 weeks old; Charles Rivers, Barcelona, Spain) were
housed in groups of two in cages maintained in standard condi-
tions (Servicio de Estabulario, Facultad de Medicina, Universidad
de Málaga) at room temperature (20◦± 2◦C), 40 ± 5% relative
humidity and a 12-h light/dark cycle with a dawn/dusk effect.
DRUG ADMINISTRATION
Cocaine hydrochloride was obtained from the Alcaliber Company
(Toledo, Spain), subsequent to receiving authorization from the
Spanish Agency of Medicines and Medical Devices and dissolved
in a sterile 0.9% NaCl solution immediately prior to experimen-
tation. Rats were given acute (20 mg/kg) injections, repeated
injections (20 mg/kg) and/or an acute challenge injection (prim-
ing, 10 mg/kg) of cocaine. Both Rimonabant and AM630 were
dissolved in 1% Tween 80 and a sterile 0.9% NaCl solution and
administered at a dose of 3 mg/kg. The drugs were injected
intraperitoneally (i.p.) in ﬁnal volumes of 1 ml/kg.
BrdU ADMINISTRATION
Doses of 50 mg/kg of 5-bromo-2′-deoxyuridine (BrdU, cat. no.
B5002, Sigma, St. Louis, MO, USA) were dissolved at 15 mg/mL
in a 0.9% saline solution and administered i.p. three times prior
to, immediately after and 8 h after the single (acute group) or the
ﬁnal (repeated cocaine injection groups) cocaine doses.
BEHAVIORAL STUDIES
Open ﬁeld test
Four open ﬁeld (OF) mazes with gray backgrounds and dimen-
sions (in cm) of L50 × W50 × H50 were used (Panlab, Barcelona,
Spain). The arenas were uniformly illuminated by a ﬂuorescent
lamp, and the light intensities at the centers of the arenas were
50–70 lx. All behavioral procedures were carried out between 8:00
a.m. and 6:00 p.m. The animals were placed individually in the
center of each arena after treatments, and their behaviors were
recorded and analyzed for 20 min with a video tracking system
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(Smart®, Panlab, Barcelona, Spain). The apparatus was cleaned
between sessions with 70% ethanol and then dried. Locomotor
activity was assessed by measuring the total distance traveled (in
cm) by each rat. The testing orders of the groups and the treat-
mentswere counterbalanced in all behavioral experiments to avoid
confounding effects of the time of the day at which the animals
were tested.
Handling and acclimation
The animals were weighed, handled (10 min) and habituated
daily to the injection procedures (i.e., they were held and pseudo-
injected) over 1 week to minimize stress effects. For the pseudo-
injection, the lower abdomen of the rat was pressed with a capped
syringe. Before beginning the experiment each day, the animals
were acclimated to the testing room for 20 min.
Locomotor activity after acute and repeated administration of
cocaine and co-administration of cocaine and Rimonabant or
AM630
One group of animals received a vehicle injection, and these
animals were immediately placed in the OF for 20 min to mea-
sure spontaneous locomotor activity. Twenty-four hours later,
the animals were re-exposed to the OF for 20 min to assess the
effects of the administration of vehicle or the acute administra-
tion of cocaine (20 mg/kg). The animals also received BrdU as
described above (Figure 1). This groupof animals (i.e., the vehicle-
injected and cocaine-exposed group) was sacriﬁced and perfused
6 days after cocaine injection. A separate group of animals was
used to assess locomotion responses after co-administration of
cocaine with either vehicle, Rimonabant or AM630. The experi-
mental groups that were monitored after acute co-administration
of treatments were as follows (n = 8/group): vehicle, Rimonabant
(3 mg/kg), AM630 (3 mg/kg), cocaine (20 mg/kg), Rimonabant
(3 mg/kg) + cocaine (20 mg/kg), andAM630 (3 mg/kg) + cocaine
(20 mg/kg). An independent group of animals of the same size
and treatment distribution was also tested in the OF for 20 min
after the injection of vehicle injection (day 1); over the following
4 days (days 2–5), these animals received repeated administrations
of vehicle, Rimonabant, AM630, or cocaine or repeated co-
administration of cocaine andRimonabant orAM630 as described
above (n = 8/group; Figure 1). On the ﬁnal day of cocaine
administration, BrdU was also administered.
Cocaine-induced conditioned locomotion and sensitization
After the repeated treatments were completed, the animals were
left undisturbed in their home cages from day 5 to day 9 (resting
period). On the 10th day, we assessed conditioned locomo-
tion responses and the locomotor activity responses induced by
the contextual memories formed through the association of the
repeated administrations of cocaine and the place in which the
cocaine exerted its stimulant effects. To this end, the animals were
injected with vehicle and placed in the OF, and their locomotions
were recorded for 10 min. On the following day (day 11), we tested
the rats’ responses to a single dose of cocaine (a lower priming dose
of cocaine, 10 mg/kg) in the OF context that had previously been
associated with cocaine administration (Figure 1). The cocaine-
induced sensitization responses of the animals were evaluated for
30 min in the OF test.
SAMPLE COLLECTION
The following seven experimental groups (n = 8/group) were
processed for histology: vehicle, acute cocaine, repeated cocaine,
Rimonabant, AM630, repeated cocaine + Rimonabant and
repeated cocaine + AM630. The animals were anesthetized
(sodium pentobarbital, 50 mg/kg, i.p.) 1 h after the ﬁnal admin-
istration of vehicle or cocaine in a room that as isolated from the
other experimental animals. The animals were then transcardially
perfused with 4% paraformaldehyde in 0.1 M phosphate-buffered
FIGURE 1 | Schematic representation of the treatments and the
behavioral protocols used in this study. The locomotor activities of
two independent groups of rats were evaluated in the OF after acute
and repeated administration of cocaine and co-administration of
cocaine (20 mg/kg) and Rimonabant (3 mg/kg) or AM630 (3 mg/kg).
Conditioned locomotion responses (5 days after last cocaine injection)
and cocaine-induced sensitization with priming doses of cocaine
(10 mg/kg) were evaluated. After treatments, all animals were tested
daily in the OF, and locomotion was measured for 20 min. Three
doses of BrdU were administered to each animal prior to, immediately
after and 8 h after the last cocaine injection for the analyses of brain
cell proliferation.
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saline (PBS), and their brains were dissected and maintained in
the same ﬁxative solution overnight at 4◦C. The brains were then
cut into 40-μm-thick coronal sections and divided into ﬁve par-
allel series using a vibratome (Leica VT1000S). The sections were
stored at 4◦C in PB with 0.002% (w/v) sodium azide until further
use for immunohistochemistry.
BrdU IMMUNOHISTOCHEMISTRY
To analyze cell proliferation in the SVZ of the lateral ventricles and
the SGZ of DG, free-ﬂoating coronal sections from 2.28 to −0.24
and from −2.16 to −4.20 relative to bregma (Paxinos andWatson,
2007) were selected from one of the ﬁve parallel series obtained
from each brain of the rats in the seven experimental groups. The
sections were ﬁrst washed several times with PBS to remove the
sodium azide and then incubated in a solution of 3% hydrogen
peroxide and 10% methanol in 0.1 M PB for 45 min at room
temperature in darkness to inactivate the endogenous peroxidase.
After three washes in PBS for 10 min, the DNA was denatured by
exposing the sections to 2 M HCl for 15 min at 37◦C, and this
process was followed by two washes in 0.15 M borate buffer to
neutralize the pH. After three 10 min washes in PBS, the sections
were incubated in a blocking solution containing 0.3% albumin,
0.3% triton X-100, and 0.05% sodium azide in PBS for 45 min.
The sections were then incubated overnight in mouse anti-BrdU
(1:2000, Hybridoma Bank, Iowa City, IA, USA; ref. G3G4) at 4◦C
(Cifuentes et al., 2011; Rivera et al., 2011). The following day, the
sections were washed three times with PBS, incubated in biotiny-
lated goat anti-mouse immunoglobulin G (IgG; H + L; 1:1000,
Pierce, Rockford, IL, USA; cat. no. 31800) for 90 min, washed
again in PBS and incubated in avidin–biotin peroxidase complex
(Pierce) diluted 1:250 in PBS in darkness at room temperature for
45 min. After three washes in PBS in darkness, immunolabeling
was revealed with 0.05% diaminobenzidine (DAB; Sigma), 0.05%
nickel ammonium sulfate and 0.03% H2O2 in PBS. After several
washes in PBS, the sections were mounted in slides treated with
poly-l-lysine solution (Sigma), air-dried, dehydrated in ethanol,
cleared with xylene and coverslipped with Eukitt mounting
medium (Kindler GmBH & Co, Freiburg, Germany). Digital high-
resolution photomicrographs of the rat brains were taken under
constant light, brightness and contrast conditions with an Olym-
pus BX41 microscope equipped with an Olympus DP70 digital
camera (Olympus Europa GmbH, Hamburg, Germany). Repre-
sentative digital images weremounted and labeled usingMicrosoft
PowerPoint 2007.
CLEAVED CASPASE-3, GFAP, AND Iba-1 IMMUNOHISTOCHEMISTRY
To analyze the immunohistochemical expression of cleaved
caspase-3, glial ﬁbrillary acidic protein (GFAP), and Iba-1 in the
striatumand thehippocampus, free-ﬂoating coronal sections from
2.28 to −0.24 and from −2.16 to −4.20 relative to bregma levels
(Paxinos and Watson, 2007) were selected from one of ﬁve parallel
series obtained from each brain of the rats in the seven experi-
mental groups. One immunostaining batch containing 56 slides
(seven groups, eight animals each) was stained simultaneously to
avoid variations in staining intensity due to the staining proce-
dures. Free-ﬂoating sections were ﬁrst washed several times with
PBS to remove the sodium azide and then incubated in sodium
citrate (50 mM in dH2O, pH 6) for 30 min at 80◦C. This process
was followed by three 10 min washes in PBS and incubation in 3%
hydrogen peroxide in PBS for 20 min in darkness at room tem-
perature to inactivate endogenous peroxidase. The sections were
then incubated in a blocking solution containing 10%serum(don-
key or goat), 0.3% triton X-100, and 0.1% sodium azide in PBS
for 1 h. The sections were incubated overnight in the following
diluted primary antibodies at 4◦C: rabbit anti-cleaved caspase-3
(1:500, Cell Signaling; cat. no. 9661), mouse anti-GFAP (1:500,
Sigma; cat. no. G3893), or rabbit anti-Iba-1 (1:1000,Wako, Osaka,
Japan; cat. no. 019-19741). The following day, the sections were
incubated with one of the following secondary antibodies for 1 h
as appropriate: biotinylated goat anti-mouse IgG (1:500, Sigma;
cat. no. B7264) or biotinylated donkey anti-rabbit IgG (1:500,
Amersham, Little Chalfont, England; cat. no. RPN 1004). The
sections were then washed three times with PBS and incubated
in ExtrAvidin peroxidase (Sigma, St. Louis, MO, USA) diluted
1:2000 in darkness at room temperature for 1 h. After three washes
in PBS in darkness, we revealed the immunolabeling with 0.05%
DAB (Sigma), 0.05% nickel ammonium sulfate, and 0.03% H2O2
in PBS. The next histological steps were performed as described
above. Digital high-resolution photomicrographs of the rat brains
were taken using conditions and equipment that were identical to
those described above.
QUANTIFICATION OF BrdU, CLEAVED CASPASE-3, GFAP, AND
Iba1-IMMUNOREACTIVE CELLS
To quantify cell proliferation in the SVZ and SGZ and apoptosis
and gliosis in the striatum and the hippocampus, immunore-
active (-ir) nuclei and cells that came into focus were manually
counted using a standard optical microscope with a 40 × objec-
tive. BrdU-ir nuclei in the SVZ and SGZ and cleaved caspase-3-,
GFAP- and Iba1-ir cells of the striatum and hippocampal DG,
CA3, and CA1 regions were counted from 2.28 to −0.24 and
from −2.16 to −4.20 relative to bregma, respectively (Paxinos
and Watson, 2007); thus, twenty 40-μm thick coronal sections per
animal were used. We considered the same numbers of sections
per brain region for each analyzed animal. Cell counts were per-
formed in both cerebral hemispheres in all cases. The results are
expressed as the average numbers of ir nuclei/cells per section
or area (mm2) for each of the following experimental group
(n = 8/group): vehicle, acute cocaine, repeated cocaine, Rimon-
abant, AM630, repeated cocaine + Rimonabant and repeated
cocaine + AM630.
QUANTIFICATION OF GFAP IMMUNOREACTIVITY
Digital high-resolution microphotographs of the striatum and
hippocampus were taken with a 10 × objective under con-
stant light, brightness and contrast conditions with an Olym-
pus BX41 microscope equipped with an Olympus DP70 dig-
ital camera. Densitometric quantiﬁcations of the immunore-
activities of representative areas were determined using the
ImageJ 1.38X (NIH, MD, USA) analysis software. In each tis-
sue section, we focused on the dorsal striatum, the hippocampal
CA1 and CA3 areas of Ammon’s horn and the DG. For both
CA areas, we considered the following layers: stratum oriens
(SO), stratum pyramidale (SP), stratum radiatum (SR), stratum
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lucidum (SL), and stratum lacunosum-moleculare (SL-M). For
the DG, we considered following layers; the molecular layer
(ml), the granular cell layer (gcl) and the polymorphic cell layer
(pcl).
STATISTICAL ANALYSIS
The data are represented as the mean ± the SEM from at least
eight animals. Kolmogorov–Smirnov normality tests indicated
that all data followed Gaussian distributions (P > 0.1); thus,
parametric statistical tests were selected. Statistical analyses of the
histological data were performed with one-way ANOVA. Behav-
ioral data were analyzed with one- or two-way repeated measures
ANOVA with the factors of time (days) and treatment (vehi-
cle, Rimonabant, AM630, cocaine, Rimonabant + cocaine and
AM630 + cocaine) followed by Bonferroni post hoc tests for
multiple comparisons. P values less than 0.05 were considered
statistically signiﬁcant.
RESULTS
EFFECT OF ACUTE AND REPEATED ADMINISTRATION OF COCAINE AND
CO-ADMINISTRATION OF COCAINE AND RIMONABANT OR AM630
To study the interaction of the pharmacological blockade of CB1
and CB2 receptors and the acute stimulating effects of cocaine,
we evaluated locomotor responses to acute doses of cannabinoid
receptor antagonists (Rimonabant or AM630 at 3 mg/kg, i.p.)
that were administered alone or in combination with cocaine
(20 mg/kg, i.p.; Figure 2A). All animals received an adminis-
tration of vehicle on day 1 and the treatment administration
24 h later. A two-way ANOVA revealed that the main effects
of group and day and the interaction between group and day
were all signiﬁcant [F(5,42) = 8.39, P < 0.001; F(1,42) = 21.71,
P < 0.001; F(5,42) = 8.36, P < 0.001, respectively]. Post hoc
comparisons revealed that the groups that received acute injections
cocaine (alone and in combination with Rimonabant or AM630)
exhibited similar signiﬁcant increases in locomotion (Figure 2A).
Moreover, post hoc analysis indicated that these groups displayed
signiﬁcantly enhanced locomotor activity compared to the groups
that received an acute dose of vehicle or CB1 and CB2 antago-
nists during the second exposure to the OF (Figure 2A). Further
post hoc comparisons revealed a reduction in locomotion after
a single administration of Rimonabant. In general, these results
indicate that acute co-administration of CB1 and CB2 antago-
nists with cocaine did not affect the acute stimulating effects of
cocaine.
To determine whether cannabinoid receptor antagonism mod-
ulates the acquisition of cocaine conditioning processes in the
OF, we assessed the effects of repeated co-administration of
CB1 and CB2 antagonists with cocaine. After an initial day on
which all experimental groups received vehicle injection, the ani-
mals received repeated administrations of vehicle, Rimonabant,
AM630, or cocaine or co-administration of cocaine and Rimona-
bant or AM630 for four consecutive days (Figure 2B). A repeated-
measures ANOVA revealed that the main effects of treatment
[F(5,42) = 52.57, P < 0.001)], day [F(4,168) = 17.82, P < 0.001],
and the day x treatment interaction [F(20,168) = 7.41, P < 0.001]
were all signiﬁcant. Post hoc comparisons indicated that the three
groups that received cocaine (alone or in combination with CB1
and CB2 antagonists) exhibited signiﬁcantly increased locomotor
activity over all 4 days of cocaine conditioning acquisition relative
to the vehicle-, Rimonabant- and AM630-treated groups (no dif-
ferences between these latter groups were found). However, post
hoc analyses also revealed that the cocaine + Rimonabant group
FIGURE 2 | (A) Effects of acute administration of cocaine and
co-administration of cocaine (20 mg/kg) and Rimonabant (3 mg/kg) or
AM630 (3 mg/kg) in the OF test. The acute cocaine-treated groups
(cocaine, cocaine + Rimonabant and cocaine + AM630) exhibited
signiﬁcant increases in locomotor activity compared to the previous
vehicle administration on day 1 (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001)
and compared to the vehicle group (#P < 0.05, ##P < 0.01,
###P < 0.001). (B) The effects of repeated administration of cocaine and
co-administration of cocaine (20 mg/kg) and Rimonabant (3 mg/kg) or
AM630 (3 mg/kg) in the OF test. The repeated cocaine-treated groups
(cocaine, cocaine + Rimonabant and cocaine + AM630) exhibited greater
locomotion than did the groups that did not receive cocaine (vehicle,
Rimonabant and AM630) on days 2 (#P < 0.05), 3 (##P < 0.01), 4 and 5
(###P < 0.001). The cocaine + Rimonabant group exhibited reduced
horizontal locomotion on days 4 and 5 compared to the other repeated
cocaine-treated groups (cocaine and cocaine + AM630; +P < 0.05,
++P < 0.01). All results are presented as the means ± the SEMs
(n = 8/group).
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exhibited reduced horizontal locomotion on days 3 and 4 rela-
tive to the other groups that received repeated cocaine injections
(i.e., the cocaine and cocaine + AM630 groups; Figure 2B). These
results may indicate that the co-administration of Rimonabant
may attenuate the acquisition of cocaine-sensitized responses.
EFFECT OF REPEATED ADMINISTRATION OF COCAINE AND
CO-ADMINISTRATION OF COCAINE AND RIMONABANT OR AM630 ON
CONDITIONED LOCOMOTION AND SENSITIZATION RESPONSES
Repeated injections of cocaine-induced a conditioned locomo-
tion response in the cocaine-treated group relative to the vehicle
group (P < 0.05). Although the cocaine + Rimonabant and
cocaine + AM630 groups were repeatedly injected with cocaine,
only the cocaine-treated group exhibited a normal conditioned
locomotor response (Figure 3A). The attenuated expression of
conditioned locomotion in the cocaine + Rimonabant group may
have been due to weaker acquisition of cocaine conditioning (days
3–4; Figure 2B).
On the following day, we measured cocaine-induced sensi-
tization with an acute challenge injection of cocaine (priming,
10 mg/kg). A one-way ANOVA revealed that the main effect of
group was signiﬁcant [F(5,45) = 5.17, P < 0.001]. Our results
revealed that the groups that received repeated cocaine injections
(20 mg/kg) alone or in combination with CB1 and CB2 antag-
onists (i.e., the cocaine + Rimonabant and cocaine + AM630
groups) exhibited signiﬁcantly increased locomotor activity com-
pared to their control groups (P < 0.05 and 0.01, respec-
tively; Figure 3B) as a result of cocaine-induced sensitization.
In brief, cannabinoid receptor antagonism (with Rimonabant
or AM630) did not affect the expression of cocaine-induced
sensitization.
EFFECT OF ACUTE AND REPEATED ADMINISTRATION OF COCAINE AND
CO-ADMINISTRATION OF COCAINE WITH RIMONABANT OR AM630 ON
NEWBORN CELLS IN RELEVANT NEUROGENIC ZONES
To investigate the effects of acute and repeated cocaine
administration and co-administration of cocaine with the CB1
and CB2 antagonists Rimonabant and AM630 on cell prolifer-
ation in the relevant neurogenic zones, we evaluated newborn
cells in the SVZ and SGZ via analyses of BrdU labeling (50 mg/kg;
(Figure 4). Both the acute and repeated cocaine-treated rats exhib-
ited lower numbers of BrdU-ir cells in the SVZ compared to the
vehicle-treated rats (∗∗∗P < 0.001; Figures 4A,C–E). Interest-
ingly, the numbers of BrdU-ir cells were signiﬁcantly lower in
the SVZs of the acute compared to the repeated cocaine-treated
rats ($$$P < 0.001). Moreover, both AM630 and Rimona-
bant also produced signiﬁcant reductions in the numbers of
BrdU-ir cells of the SVZ compared to vehicle (∗∗P < 0.01 and
∗∗∗P < 0.001, respectively; Figures 4A,F,H). Repeated AM630 or
Rimonabant co-administration with cocaine resulted in further
signiﬁcant reductions in the numbers of BrdU-ir cells observed
in the SVZs of the repeated cocaine-treated rats ($$P < 0.01;
Figures 4A,G,I).
Lower numbers of BrdU-ir cells were observed in the SGZs
of the acute cocaine-treated rats than in the vehicle-treated rats
(∗P < 0.05) or the repeated cocaine-treated rats ($$$P < 0.001;
Figures 4B,J–L). Thus, no differences in the numbers of BrdU-
ir cells were found in the SGZs of the repeated cocaine-treated
rats compared to the vehicle rats. In contrast, both AM630
and Rimonabant induced increases in the numbers of BrdU-
ir cells in the SGZ compared to vehicle (∗∗P < 0.01 and
∗P < 0.05, respectively; Figures 4B,M,O). The increases in the
numbers of BrdU-ir cells after repeated AM630 or Rimonabant
FIGURE 3 | (A) Effects of repeated administration of cocaine and
co-administration of cocaine (20 mg/kg) and Rimonabant (3 mg/kg) or AM630
(3 mg/kg) on the conditioned locomotion response measured in the OF test.
Five days after the ﬁnal cocaine injection, only the cocaine-treated group
exhibited elevated conditioned locomotion responses compared to the
vehicle group (∗P < 0.05) after a vehicle injection. (B) Effects of repeated
administration of cocaine and co-administration of cocaine (20 mg/kg) and
Rimonabant (3 mg/kg) or AM630 (3 mg/kg) on cocaine-induced sensitization
measured in the OF test. The repeated cocaine-treated groups (cocaine,
cocaine + Rimonabant and cocaine + AM630) exhibited signiﬁcantly
enhanced cocaine-sensitized responses after receiving an acute challenge
injection (priming, 10 mg/kg) compared to the groups that did not receive
cocaine (vehicle, Rimonabant and AM630; ∗P < 0.05, ∗∗P < 0.01). All results
are presented as the means ± the SEMs (n = 8/group).
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FIGURE 4 | Continued
FIGURE 4 | Continued
Effects of repeated administration of cocaine and co-administration of
cocaine (20 mg/kg) and Rimonabant (3 mg/kg) or AM630 (3 mg/kg) on
cell proliferation in the SVZ (A) and the SGZ (B) as measured with
BrdU immunohistochemistry. Repeated AM630 or Rimonabant
administration increased the numbers of BrdU-ir cells observed in the SVZ
and SGZ of the repeated cocaine-treated rats. (C–P) Representative
microphotographs showing low- and high-magniﬁcation (insets) views of
the typical clusterings of newborn cells in the subventricular zone of the
lateral ventricle and the inner border of the granular cell layer. The histogram
displays the means ± SEMs (n = 8/group) of the numbers of BrdU-ir nuclei
per area (mm2). One-way ANOVA: ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 vs.
vehicle group; $$P < 0.01, $$$P < 0.001 vs. repeated cocaine group;
###P < 0.001 vs. Rimonabant group. Scale bars are included in each image.
administration were maintained ($$P < 0.01) and increased
($$$P < 0.001), respectively, in the SGZs of repeated cocaine-
treated rats (Figures 4B,N,P).
EFFECT OF ACUTE AND REPEATED ADMINISTRATION AND
CO-ADMINISTRATION OF COCAINE WITH RIMONABANT OR AM630 ON
APOPTOTIC CELLS IN THE STRIATUM AND THE HIPPOCAMPUS
Apoptotic cells, as determined by cleaved caspase-3 immunos-
taining, were assessed in the striata and the hippocampal DG,
CA1, and CA3 areas of rats that were administered acute or
repeated cocaine with in combination with the CB1 and CB2
antagonists Rimonabant and AM630, respectively (Figure 5).
No differences in the numbers of cleaved caspase 3-ir cells were
detected in the striata of the acute or repeated cocaine-treated rats
compared to the vehicle-treated rats (Figures 5A,C–E). Rimona-
bant, but not AM630, produced a small but signiﬁcant reduction
in the number of cleaved caspase 3-ir cells in the striatum
(∗P < 0.05; Figures 5A,F,H). This reduction in the number of
cleaved caspase 3-ir cells in the striatum was also present after the
co-administration of cocaine and Rimonabant compared to the
vehicle- or repeated cocaine-treated rats (∗P < 0.05, $P < 0.05;
Figures 5A,G,I).
Increased numbers of cleaved caspase 3-ir cells were observed
in the hippocampi of both acute and repeated cocaine-treated
rats (∗∗∗P < 0.001; Figures 5B,J–L). Regarding the three hip-
pocampal areas analyzed (i.e., the DG, CA1, and CA3), increased
numbers of cleaved caspase 3-ir cells were found in the DG
and CA1 areas of both the acute and repeated cocaine groups
(∗∗∗P < 0.001 and ∗∗P < 0.01, respectively) and in the CA3
area of the acute cocaine group (∗∗P < 0.01). In contrast,
no increase was detected in the CA3 areas of the repeated
cocaine-treated rats (Figures 5B,J–L). AM630 but not Rimona-
bant produced a small increase in the number of cleaved caspase
3-ir cells in the hippocampus (∗P < 0.05), and this result
was the a consequence of the prominent increase in the num-
ber of cleaved caspase 3-ir cells that was speciﬁcally observed
in the DG (∗∗∗P < 0.001) and not in the CA1 and CA3
ﬁelds (Figures 5B,M,O). Interestingly, we observed decreases
in the numbers of hippocampal cleaved caspase 3-ir cells after
repeated AM630 or Rimonabant administration in the repeated
cocaine-treated rats ($P < 0.05 and $$P < 0.01, respectively;
Figures 5B,N,P).
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FIGURE 5 | Effects of repeated administration of cocaine and
co-administration of cocaine (20 mg/kg) and Rimonabant (3 mg/kg) or
AM630 (3 mg/kg) on cell apoptosis in the striatum (A) and
hippocampus (B) as measured with cleaved caspase-3
immunohistochemistry. Rimonabant administration decreased the
numbers of cleaved caspase 3-ir cells observed in the striata and
hippocampi of the repeated cocaine-treated rats. Only AM630 decreased
the numbers of cleaved caspase 3-ir cells in the hippocampi of the
repeated cocaine-treated rats. (C–P) Representative microphotographs
showing low- and high-magniﬁcation (insets) views of apoptotic cells in the
striatum and hippocampus. The histogram displays the means ± SEMs
(n = 8/group) of the numbers of cleaved caspase 3-ir cells per area (mm2).
One-way ANOVA: ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 vs. vehicle group;
$P < 0.05, $$P < 0.01 vs. repeated cocaine group; ##P < 0.01,
###P < 0.001 vs. Rimonabant group. Scale bars are included in each image.
EFFECTS OF ACUTE AND REPEATED ADMINISTRATION OF COCAINE
AND CO-ADMINISTRATION OF COCAINE WITH RIMONABANT OR
AM630 ON ASTROGLIOSIS IN THE STRIATUM AND THE HIPPOCAMPUS
To investigate the effects of acute and repeated cocaine
administration and the co-administration of the CB1 and CB2
antagonists Rimonabant and AM630 on astrogliosis, we evalu-
ated the intensities of GFAP immunoreactivity and the numbers
of astrocytes expressing GFAP in the striatum and the hip-
pocampal DG, CA1, and CA3 areas (Figure 6). A greater
number of GFAP-ir cells were observed in the striatum of
the acute cocaine-treated rats compared to the vehicle-treated
(∗∗P < 0.01) and repeated cocaine-treated rats ($$$P < 0.001;
Figures 6A,E–G). Thus, no differences in the numbers of GFAP-ir
cells were observed in the striata of the repeated cocaine-treated
rats compared to the vehicle-treat rats. Moreover, the stri-
ata of the rats treated with AM630 or Rimonabant did not
exhibit differences in the numbers of GFAP-ir cells when com-
pared to the vehicle group (Figures 6A,H,J). A speciﬁc decrease
in the numbers of GFAP-ir cells was observed in the striata
of the repeated cocaine-treated rats that were co-administered
AM630 ($P < 0.05) but not Rimonabant (Figures 6A,I,K).
Analyses of GFAP immunoreactivity intensities in the striatum
(Figure 6B) revealed no differences between the vehicle-, acute
cocaine- and repeated Rimonabant groups (Figures 6B,E,F,J).
In contrast, decreases in GFAP immunostaining were detected
in the striata of the repeated cocaine- and AM630-treated
rats (∗P < 0.05; Figures 6B,G,H). No effects of repeated
AM630 or Rimonabant treatment on GFAP expression were
observed in the striata of the repeated cocaine-treated rats
(Figures 6B,I,K).
Greater numbers of GFAP-ir cells were observed in the hip-
pocampi of the acute and repeated cocaine-treated rats and the
AM630 and Rimonabant-treated rats compared to the vehicle-
treated rats (∗∗∗P < 0.001; Figures 6C,L–N,O,Q). These effects
were accompanied by different levels of signiﬁcance across the
three analyzed regions of the hippocampus (i.e., the DG, CA1,
and CA3). Notably, the increase in the number of GFAP-ir
cells was signiﬁcantly greater in the hippocampi of the acute
cocaine group than in the hippocampi of the remaining groups
including the repeated cocaine group ($$P < 0.01). Specif-
ically, this difference in GFAP-ir cell numbers between the
acute and repeated cocaine groups was observed in the CA1
and CA3 ﬁelds ($$$P < 0.001) and not in the DG. The hip-
pocampi of the repeated cocaine-treated rats that also received
repeated AM630 or Rimonabant exhibited decreases in the num-
bers of GFAP-ir cells ($$P < 0.01), particularly in the DG
($$$P < 0.001 and $$P < 0.01 for the AM630 and Rimonabant
co-administration groups, respectively) and not in the CA3 ﬁeld
(Figures 6C,P,R). Analyses of GFAP immunoreactivity intensities
in the hippocampus (Figure 6D) revealed more intense immunos-
taining in the acute and repeated cocaine-treated rats compared
to the vehicle-treated rats (∗∗∗P < 0.001; Figures 6D,L–N).
Across all hippocampal regions analyzed (i.e., DG, CA1, and
CA3), GFAP immunoreactivity was more intense in the acute
cocaine-treated rats than in the repeated cocaine-treated rats
($$P < 0.01). Notably, no effects of pharmacological blockade of
CB1 or CB2 receptors on GFAP immunoreactivities were observed
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FIGURE 6 | Effects of repeated administration of cocaine and
co-administration of cocaine (20 mg/kg) and Rimonabant (3 mg/kg) or
AM630 (3 mg/kg) on astrogliosis in the striatum (A,B) and the
hippocampus (C,D) as measured with GFAP immunohistochemistry.
AM630 administration decreased the numbers of GFAP-ir cells observed in
the striata of the repeated cocaine-treated rats. Both AM630 and Rimonabant
induced decreases in the numbers of GFAP 3-ir cells and reduced the
intensities of GFAP immunoreactivity in the hippocampi of the repeated
cocaine-treated rats. (E–R) Representative microphotographs showing low-
and high-magniﬁcation (insets) views of astroglial cells in the striatum and
hippocampus. The histogram displays the means ± the SEMs (n = 8/group) of
the numbers of GFAP-ir cells per area (mm2) and GFAP immunoreactivities
(arbitrary units). One-way ANOVA: ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 vs.
vehicle group; $P < 0.05, $$P < 0.01,$$$P < 0.001 vs. repeated cocaine
group; &P < 0.05, &&P < 0.01 vs. AM630 group; ##P < 0.01, ###P < 0.001
vs. Rimonabant group. Scale bars are included in each image.
when the total hippocampi were analyzed (Figures 6D,O,Q).
However, decreases in GFAP immunostaining were speciﬁcally
observed in the CA3 ﬁelds of rats that were administered
AM630 (∗∗P < 0.01) or Rimonabant (∗P < 0.05) compared
to the vehicle group. Moreover, repeated administrations of
AM630 or Rimonabant induced decreases in GFAP immunos-
taining in the hippocampi of the repeated cocaine-treated rats
(Figures 6D,P,R).
EFFECTS OF ACUTE AND REPEATED ADMINISTRATION OF COCAINE
AND CO-ADMINISTRATION OF COCAINE WITH RIMONABANT OR
AM630 ON MICROGLIOSIS IN THE STRIATUM AND THE HIPPOCAMPUS
To investigate the effects of the acute and repeated cocaine
administration and co-administration with the CB1 and CB2
antagonists Rimonabant and AM630 on microgliosis, we eval-
uated the numbers of cells that expressed Iba1 in the striatum
and the hippocampal DG, CA1, and CA3 areas (Figure 7). No
differences in the numbers of Iba-ir cells were observed in the
striata of the acute or repeated cocaine-treated rats or the AM630-
or Rimonabant-treated rats compared to the vehicle-treated rats
(Figures 7A,C–F,H). However, the numbers of Iba1-ir cells were
higher in the striata of the acute cocaine-treated rats than in
the repeated cocaine-treated rats ($P < 0.05; Figures 7A,C–E).
Interestingly, we observed decreases in the numbers of striatal
Iba1-ir cells after repeated AM630 or Rimonabant administration
in the repeated cocaine-treated rats ($$$P < 0.001 and $$P < 0.01,
respectively; Figures 7A,G,I).
Increased numbers of Iba1-ir cells were observed in the hip-
pocampi of both the acute and repeated cocaine-treated rats
(∗∗∗P < 0.001; Figures 7B,J–L). Regarding the three analyzed
hippocampal areas (i.e., the DG, CA1, and CA3), increased num-
bers of Iba1-ir cells were found in the DG and CA1 areas of both
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FIGURE 7 | Effects of repeated administration of cocaine and
co-administration of cocaine (20 mg/kg) and Rimonabant (3 mg/kg) or
AM630 (3 mg/kg) on microgliosis in the striatum (A) and the
hippocampus (B) as measured with Iba-1 immunohistochemistry.
AM630 and Rimonabant administration decreased the numbers of Iba1-ir
cells observed in the striata but not the hippocampi of the repeated
cocaine-treated rats. (C–P) Representative microphotographs showing low-
and high-magniﬁcation (insets) views of microglial cells in the striatum and
hippocampus. The histogram displays the means ± the SEMs (n = 8/group)
of the numbers of Iba1-ir cells per area (mm2). One-way ANOVA: ∗P < 0.05,
∗∗P < 0.01, ∗∗∗P < 0.001 vs. vehicle group; $P < 0.05, $$P < 0.01,
$$$P < 0.001 vs. repeated cocaine group;&&&P < 0.001 vs. AM630 group;
#P < 0.05 vs. Rimonabant group. Scale bars are included in each image.
the acute and repeated cocaine groups (∗P < 0.05). In contrast,
no changes and a decrease (∗P < 0.05) in the number of Iba1-
ir cells were detected in the CA3 areas of the acute and repeated
cocaine groups, respectively. Notably, the increase in the num-
ber of Iba1-ir cells was signiﬁcantly greater in the hippocampus
of the acute cocaine group than in the repeated cocaine group
($$$P < 0.001). Speciﬁcally, this difference in Iba1-ir cell numbers
between the acute and repeated cocaine groups was observed in
the CA1 and CA3 ﬁelds ($P < 0.05 and $$$P < 0.001, respec-
tively) and not in the DG (Figures 7B,J–L). Greater numbers of
Iba1-ir cells were also observed in the hippocampi of the AM630
and Rimonabant-treated rats compared to the vehicle-treated rats
(∗∗∗P< 0.001; Figures 7B,M,O). The levels of signiﬁcance of these
effects varied across the three analyzed hippocampal regions (i.e.,
the DG, CA1, and CA3). Notably, AM630 and Rimonabant failed
to affect the numbers of Iba1-ir cells in the hippocampi (or the
speciﬁc hippocampal regions) in the repeated cocaine-treated rats
(Figures 7B,N,P).
DISCUSSION
The present study contributes three main new ﬁndings to the
understanding of the role of cell proliferation in cocaine addiction.
First, pharmacological blockade of either CB1 or CB2 cannabinoid
receptors during the acquisition of behavioral sensitization in a
speciﬁc context affects hippocampal-dependent conditioned loco-
motion but not the expression of sensitized responses to cocaine.
Second, the absence of cocaine-induced conditioned locomotion
in the cannabinoid antagonist-treated animals was associated with
enhancements of cell proliferation in the hippocampus. Third,
cocaine-induced an activation of the glial compartment that was
partially counteracted by the blockade of either CB1 or CB2 recep-
tors. In the SVZ, repeated cocaine decreased cell proliferation,
and the blockade of either of the cannabinoid receptors partially
counteracted this effect. Overall, the present study demonstrated
that the endogenous cannabinoid system participates in the effects
of cocaine on both brain cell proliferation and the emergence of
conditioned responses associated with the administration of con-
ditioned responses associated with the administration of cocaine
(Table 1).
Conditioned locomotion is a conditioned behavioral response
in which hippocampus-dependent contextual memories of pre-
vious cocaine exposure boost behavioral arousal and locomo-
tion. In a recent study, we demonstrated this link in a mouse
model with disruptions of glutamatergic transmission and deﬁcits
in neurogenesis in the hippocampus; in the Málaga variant
of the lysophosphatidic acid type 1 receptor knockout mice
(Matas-Rico et al., 2008; Blanco et al., 2012), hippocampal alter-
ations are associated with profound disruptions of cocaine-
induced conditioned locomotion responses (Blanco et al., 2012)
but not cocaine-induced sensitization. Although in the present
work we do not provide direct evidence linking the cell prolif-
eration responses activated by cannabinoid receptor blockade to
the disappearance of conditioned locomotion, there is growing
evidence linking the restoration of hippocampal neurogenesis to
extinction and protection against cocaine seeking behaviors (Noo-
nan et al., 2008, 2010; Mandyam and Koob, 2012). Our results
indicate that the impairments of cell proliferation induced by
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Table 1 | Summary of the main effects of acute and repeated administration and co-administration of cocaine with Rimonabant or AM630 on
factors related to cell proliferation, apoptosis and gliosis.
Proliferation (BrdU) Apoptosis (Caspase 3) Astrogliosis (GFAP) Microgliosis (Iba1)
SVZ SGZ Str HC Str HC Str HC
Acute cocaine1 ↓ ↓ ns ↑ ↑ ↑ ns ↑
Repeated cocaine1 ↓ ns ns ↑ ns ↑ ns ↑
AM6301 ↓ ↑ ns ↑ ns ↑ ns ↑
Rimonabant1 ↓ ↑ ↓ ns ns ↑ ns ↑
Cocaine + AM6302 ↑ ↑ ns ↓ ↓ ↓ ↓ ns
Cocaine + Rimonabant2 ↑ ↑ ↓ ↓ ns ↓ ↓ ns
1Effects of acute cocaine, repeated cocaine, AM630 and Rimonabant versus vehicle.
2Effects of repeated cocaine + AM630 or Rimonabant versus repeated cocaine.
cocaine are counteracted by pharmacological blockade of either
the CB1 or CB2 cannabinoid receptor, which corroborates the
previous suggestion that cell proliferation events in the adult neu-
rogenic niche are under the control of both cannabinoid receptors
(Aguado et al., 2005; Diaz-Alonso et al., 2012). In fact, dopamine
D2/D3 receptor activation has been linked to both, enhancement
of anandamide release and reduction of neurogenesis, suggest-
ing a convergent mechanism for dopamine and anandamide in
the inhibition of cell proliferation (Rueda et al., 2002; Deschaux
et al., 2012). Although the effects on cell proliferation were more
pronounced after cannabinoid CB1 receptor blockade, the well-
known actions of CB1 blockade on anxiety precludes the use
of cannabinoid CB1 receptor blockers as a restorative therapy
in addiction (Navarro et al., 1997). Indeed, cannabinoid CB2
receptor-mediated responses aremuchmore interesting, and there
is evidence that genetic manipulation or pharmacological block-
ade of cannabinoid CB2 receptors modulates cocaine-addiction
related behaviors (Xi et al., 2011; Aracil-Fernandez et al., 2012).
Based on the present results, we speculate that the positive
outcomes of those studies also relied on the restorationof neuroge-
nesis in the hippocampus. Additionally, increased cell proliferation
in the hippocampus due to pharmacological blockade of cannabi-
noid receptors in the cocaine-treated rats was associated with
decreases in mortality (see the cleaved-caspase expression results),
which suggests that these new cells had the opportunity to
mature and become fully functional. In any case, further stud-
ies to address the destinies (in terms of phenotype and circuit
integration) and roles of these new hippocampal cells in the
contextual memories associated with cocaine administration are
underway.
An interesting aspect of the present results is the dissociation
between the effects of cannabinoid receptor blockade on condi-
tioned locomotion and sensitization of the responses to cocaine.
This dissociation supports the existence of multiple independent
circuits that differentially adapt to the effects of cocaine and the
differential contributions of endocannabinoids to these circuits.
While cannabinoid regulation of the hippocampalmemories asso-
ciated with cocaine has been implicated in the acquisition of
cocaine self-administration and cue-induced relapse (De Vries
et al., 2001), the actions of cannabinoid receptors on sensitization
to psychostimulants are controversial. There are reports that indi-
cate a clear role of cannabinoid receptors in the acquisition of this
behavioral adaptation to repeated cocaine exposure (Gerdeman
et al., 2008; Thiemann et al., 2008; Mereu et al., 2013). However,
there are also reports that indicate that the genetic deletion of
cannabinoid receptors has no inﬂuence on this effect of cocaine
(Lesscher et al., 2005; Thiemann et al., 2008). Under our exper-
imental conditions, we found that blockade of the cannabinoid
CB1 receptor delayed the acquisition of sensitization, but after the
animals were challenged with a 6-day period of incubation, the
response to cocaine was equally increased. This ﬁnding indicates
that, although interference with the molecular mechanisms con-
trolled by the CB1 receptors in the basal ganglia may interfere with
the molecular adaptations associated with repeated cocaine expo-
sure, the sensitized response is ultimately acquired and expressed.
Moreover, the ﬁndings that cell proliferation in the adjacent SVZ is
increased by eitherCB1 orCB2 blockade suggests that this response
is apparently not related to the sensitizationprocess,whichprimar-
ily relies on dopamine-glutamate interactions in dopaminoceptive
medium-spiny neurons in the basal ganglia (Carlezon and Nestler,
2002).
Finally, the ability of cannabinoid CB1 receptor blockade to
attenuate the glial response to cocaine is an interesting ﬁnding
of this study. As has been previously described in the medial
prefrontal cortex, both the astroglial and microglial compart-
ments were activated after cocaine exposure (Mandyam et al.,
2007). Pharmacological blockade of either cannabinoid CB1 or
CB2 receptors attenuated this reactivity and normalized the glial
compartments of the animals that received cocaine. Both glial
cell types are relevant to the induction of plastic changes in
the hippocampus and striatum, and the effects of the func-
tions of these cells on cocaine-associated behaviors demand
further investigation. However, preliminary studies have clearly
indicated that astrocytes, through the regulation of glutamate
dynamics, contribute to cocaine addiction (Mandyam et al., 2007;
Mandyam and Koob, 2012). In fact, cocaine administration
is capable of regulating the expression and activity of two of
the main enzymes that regulate synthesis of glutamate and are
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expressed in astrocytes, the K and L glutaminase isoforms (Blanco
et al., 2012). In contrast, the inﬂammatory pattern of microglia
reactivity after cocaine administration suggests that cannabi-
noid receptors might regulate this response, which is thought
to contribute to the plastic changes that result from cocaine
exposure.
Overall, the results of the present study suggest that the endoge-
nous cannabinoid system is a key regulatory element of the
plastic changes that are associated with cocaine-induced behav-
ioral responses in the rat. This modulatory role is mediated by the
signaling processes that are activated by both cannabinoidCB1 and
CB2 receptors. The neuroadaptations to cocaine that are under
cannabinoid control include cell proliferation, cell survival and
glial activation. Given the clinical withdrawal of cannabinoid CB1
antagonists, our results suggest that cannabinoid CB2 receptor
antagonists are suitable targets for the development of therapies
for cocaine addiction.
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